Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysis
BrMs from prostate cancer are rare and predominantly occur in patients with advanced, castrate-resistant disease, often accompanied by other metastases. This analysis enhances our understanding of the disease trajectory and informs treatment discussions.
Authors
- Charles Catton (ORCID: https://orcid.org/0000-0003-2248-1370)
- Ayah Erjan (ORCID: https://orcid.org/0000-0002-1567-3182)
- Dana Keilty (ORCID: https://orcid.org/0000-0001-6374-2755)
- Srinivas Raman (ORCID: https://orcid.org/0000-0001-5688-9628)
- Marc Vincent Barcelona
- Kurl Jamora (ORCID: https://orcid.org/0000-0003-1097-3116)
- Mark Bernstein (ORCID: https://orcid.org/0000-0003-4630-0108)
- Eshetu G. Atenafu (ORCID: https://orcid.org/0000-0002-4613-3680)
- Michael Yan (ORCID: https://orcid.org/0000-0002-8387-6563)
- David Shultz (ORCID: https://orcid.org/0000-0001-8242-6555)
- Aristotelis Kalyvas (ORCID: https://orcid.org/0000-0002-0222-488X)
- Normand Laperrière (ORCID: https://orcid.org/0000-0001-8930-9650)
- Gelareh Zadeh (ORCID: https://orcid.org/0000-0002-6637-4502)
- Peter Chung
- Paul N. Kongkham (ORCID: https://orcid.org/0000-0002-1047-9305)
- Alejandro Berlín (ORCID: https://orcid.org/0000-0002-1880-6905)
- Enrique Gutiérrez (ORCID: https://orcid.org/0000-0002-3524-2339)
- Barbara Ann Millar
- Tatiana Conrad
- Adeodatus Vito Nicanor
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Toronto Western Hospital (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf063
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00